Marketing-authorisation holder Β· Canada
Intervet Canada Corp
110 medicines in 1 country, as authorisation holder.
Group structure
Part of
IntervetPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1β25 of 110
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AQUAFLOR500 G / Kg Β· Drug Premix | Florfenicol | Canada | Marketed | 1997 |
| AROVYN100 mg / ml Β· Solution | Tulathromycin | Canada | Authorised | |
| BANAMINE50 mg / ml Β· Solution | Flunixin | Canada | Marketed | 1979 |
| BANAMINE50 mg / ml Β· Solution | Flunixin | Canada | Marketed | 2017 |
| BORGAL200 mg / ml + 40 mg / ml Β· Solution | Sulfadoxine, Trimethoprim | Canada | Marketed | 1986 |
| BRAVECTO1400 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO1400 mg / 5 ml Β· Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO500 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO112.5 mg / 0.4 ml Β· Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO112.5 mg / 0.4 ml Β· Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO250 mg / 0.89 ml Β· Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO500 mg / 1.79 ml Β· Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO112.5 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO1000 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO250 mg / 0.89 ml Β· Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO1000 mg / 3.57 ml Β· Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO250 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO500 mg / 1.79 ml Β· Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO ONE400 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE100 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE560 mg Β· Tablet (Chewable) | Fluralaner | Canada | Authorised | |
| BRAVECTO ONE200 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE45 mg Β· Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO QUANTUM2.51 g / vial Β· Powder For Suspension | Fluralaner | Canada | Marketed | 2025 |
| CANINSULIN40 unit / ml Β· Suspension | Insulin pork | Canada | Marketed | 2014 |



